Reactivity of monoclonal antibodies 17.13 and 63.12 with 141 oral mucosal lesions.
We studied the reactivity of monoclonal antibodies (MAbs) 17.13 and 63.12 with normal and diseased human oral mucosa by means of the immunoperoxidase technique. The specimens included: 22 normal oral tissues, 20 benign tumors, 17 lichen planus, 23 focal keratosis and epithelial hyperplasias, 18 proliferative verrucous leukoplakias, 20 dysplasias, and 21 squamous cell carcinomas. In most cases of normal mucosa and benign lesions, MAb 17.13 stained basal epithelial cells only, whereas MAb 63.12 stained all cell layers above the basal cells. In the premalignant and malignant lesions MAb 17.13 stained above the basal cells and MAb 63.12 either stained areas not stained by MAb 17.13 or the staining was absent. Based on the different staining patterns observed, there appears to be a potential value of these new reagents in diagnostic histopathology regarding specimens with equivocal cellular morphology.
D000911:Antibodies, Monoclonal; D002294:Carcinoma, Squamous Cell / Q000473:pathology; D004848:Epithelium / Q000473:pathology; D005350:Fibroma / Q000473:pathology; D005881:Gingiva / Q000166:cytology; D006801:Humans; D006965:Hyperplasia; D007124:Immunoenzyme Techniques; D007642:Keratosis / Q000473:pathology; D007972:Leukoplakia, Oral / Q000473:pathology; D008010:Lichen Planus / Q000473:pathology; D008214:Lymphocytes / Q000473:pathology; D009059:Mouth Diseases / Q000473:pathology*; D009061:Mouth Mucosa / Q000166:cytology* / Q000473:pathology; D009062:Mouth Neoplasms / Q000473:pathology*; D010859:Pigmentation Disorders / Q000473:pathology; D011230:Precancerous Conditions / Q000473:pathology*; D013194:Staining and Labeling; D014059:Tongue / Q000166:cytology
D000911:Antibodies, Monoclonal